← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vaxiion Therapeutics, Inc.
San Diego, CA
$882,369
Total funding
4
Grants
Funding over time
peak $306.3K · FY2008–25$500K$375K$250K$125K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$882,369 · 4
By mechanism
R43$882,369 · 4
Investigators at Vaxiion Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical development of VAX024 - a novel targeted combination STING agonist/oncolytic agent$306,265
R43 · FY2025 · CA
Preclinical Evaluation of VAX014 in Combination with Immune Checkpoint Inhibitors$232,276
R43 · FY2018 · CA
Immunotherapeutic minicells for use in intermediate and high-risk non-muscle inva$144,103
R43 · FY2013 · CA
Scaling up bacterial minicell production$130,000
R43 · FY2008 · GM
Immunotherapeutic minicells for use in intermediate and high-risk non-muscle inva$69,725
R43 · FY2014 · CA